Psagot Investment House

Veev Inc., established in 2017 and based in Minneapolis, Minnesota, is a hybrid real estate solutions company that focuses on transforming the construction and experience of homes. The company offers an innovative home operating system that integrates room-specific lighting, shade, and climate control, while also safeguarding against security threats and cybercrime. Veev employs a panelized building system that utilizes light gauge steel for framing and high-performance acrylic for surfaces, complemented by radiant climate control systems and a digital home ecosystem. Currently, Veev is concentrating on high-performance multifamily units and accessory dwelling units (ADUs), with a development pipeline exceeding 230 units and 620,000 gross building square feet. Their comprehensive approach includes asset management, architectural design, permitting, modular construction, installation, and a digital infrastructure that enhances safety, maintenance, and overall comfort for homeowners.

MeaTech develops complex cultured meat by combining advanced 3D printing technologies. The company's technology aims to enable the production of meat directly instead of raising the entire animal. The company takes a sample of stem cells from an animal, reproduces these cells, divides them into different meat components, and 3D prints the cultured meat in an accurate shape and structure. They plan to develop clean farming through an industrial cultured meat process without harming animals.

DarioHealth Corp. is a digital health company that specializes in developing and commercializing proprietary technology for laboratory testing via smartphones and mobile devices. Its flagship product, the Dario Smart Diabetes Management Solution, integrates a cloud-based software application with a compact blood glucose monitoring device. This solution enables users to manage their diabetes through real-time data tracking, coaching, and support, while also providing alerts and analysis of health trends. DarioHealth markets its products directly to consumers and through retail pharmacies, hospitals, and online channels. The company also offers a digital platform, DarioEngage, to enhance user engagement and support in managing chronic illnesses. Founded in 2011 and headquartered in Caesarea, Israel, DarioHealth emphasizes personalized, evidence-based interventions driven by data analytics and individual coaching, addressing various health concerns such as diabetes, hypertension, and weight management.

ElectReon revolutionizes E- mobility with the ultimate goal of eliminating the dependency on oil. It is paving the way for future green e-mobility solutions with a unique “Smart road technology”, by developing a Dynamic Wireless Electrification System for electric transportation. Its technology reduces the need for a large battery in the vehicle and powers it wirelessly via minimal infrastructure located under the driving lane. Eliminating the need to stop for recharging or refueling the vehicle during the day. Once the system has been deployed in the main roads for public transportation then it can serve as a platform for all kind of vehicles eliminating the initial costs. In addition, ElectReon can harvest energy due to vehicle braking and transfer it back to the electricity grid, it reduces the total amount of energy consumed by the transportation sector.

Protalix Biotherapeutics is a biopharmaceutical company based in Karmiel, Israel, that specializes in the development and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system. The company is primarily known for its product Elelyso, a recombinant glucocerebrosidase enzyme approved for the treatment of Gaucher disease. Protalix is advancing a diverse pipeline, including PRX-102, which is in phase III clinical trials for Fabry disease, and OPRX-106, a therapeutic candidate for inflammatory bowel disease that has completed phase IIa trials for ulcerative colitis. Additionally, PRX-110, aimed at treating cystic fibrosis, and PRX-115, a treatment for gout, are also in development. Protalix has established partnerships with leading pharmaceutical companies, including Pfizer, and has a commercial presence in Brazil and other regions of Latin America. The company aims to target significant pharmaceutical markets with its innovative therapies for genetic and inflammatory disorders.

Foresight revolutionizes the ADAS industry by enabling highly accurate and reliable object recognition while ensuring the lowest rates of false alerts.Proven core military technology has been developed, tested and deployed over the past 12 yearsUnique platform that offers ADAS for the Automotive and the Railway industries.Highly experienced management team in the stereo vision technology industry Strong IP and know-how Strategic relationships to solidify position in the market.Focused on the growing semi and fully-automated driving industry.

BLender also differentiates itself through DirectMatch, its portfolio creator, and Re-BLend, a secondary trading market within the company. Prosper and LendingClub allow lenders to invest in a variety of loans in small increments to diversify and reduce risk. BLender optimizes this process with its matching algorithm that automatically spreads lenders’ money over a wide variety of loans. With Re-BLend, lenders can buy and sell loans and portfolios among themselves, a service that is not provided by LendingClub and outsourced by Prosper.